Citizens Financial Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.52M Buy
14,160
+3,675
+35% +$395K 0.02% 288
2025
Q1
$1.06M Buy
10,485
+1,515
+17% +$153K 0.02% 313
2024
Q4
$801K Buy
8,970
+3,931
+78% +$351K 0.02% 325
2024
Q3
$422K Buy
5,039
+1,475
+41% +$124K 0.01% 406
2024
Q2
$274K Buy
+3,564
New +$274K 0.01% 460
2022
Q1
Sell
-4,995
Closed -$212K 444
2021
Q4
$212K Sell
4,995
-578
-10% -$24.5K 0.01% 424
2021
Q3
$242K Hold
5,573
0.01% 400
2021
Q2
$238K Sell
5,573
-1,593
-22% -$68K 0.01% 327
2021
Q1
$277K Hold
7,166
0.01% 260
2020
Q4
$258K Sell
7,166
-1,780
-20% -$64.1K 0.01% 259
2020
Q3
$342K Sell
8,946
-2,611
-23% -$99.8K 0.02% 200
2020
Q2
$406K Sell
11,557
-1,783
-13% -$62.6K 0.03% 207
2020
Q1
$435K Sell
13,340
-2,592
-16% -$84.5K 0.04% 195
2019
Q4
$720K Sell
15,932
-676
-4% -$30.6K 0.05% 161
2019
Q3
$676K Sell
16,608
-608
-4% -$24.7K 0.05% 154
2019
Q2
$740K Sell
17,216
-201,078
-92% -$8.64M 0.05% 148
2019
Q1
$8.38M Buy
218,294
+800
+0.4% +$30.7K 0.62% 56
2018
Q4
$7.69M Sell
217,494
-942
-0.4% -$33.3K 0.7% 56
2018
Q3
$8.41M Sell
218,436
-4,380
-2% -$169K 0.66% 56
2018
Q2
$7.29M Sell
222,816
-6,626
-3% -$217K 0.61% 58
2018
Q1
$6.27M Sell
229,442
-9,095
-4% -$248K 0.53% 70
2017
Q4
$5.91M Buy
238,537
+6,237
+3% +$155K 0.48% 72
2017
Q3
$6.78M Sell
232,300
-10,620
-4% -$310K 0.58% 63
2017
Q2
$6.73M Sell
242,920
-10,689
-4% -$296K 0.6% 67
2017
Q1
$6.31M Sell
253,609
-93,510
-27% -$2.33M 0.56% 68
2016
Q4
$7.51M Sell
347,119
-16,990
-5% -$367K 0.73% 54
2016
Q3
$8.67M Sell
364,109
-192
-0.1% -$4.57K 0.82% 50
2016
Q2
$8.51M Sell
364,301
-5,958
-2% -$139K 0.82% 49
2016
Q1
$6.97M Sell
370,259
-120,307
-25% -$2.26M 0.67% 61
2015
Q4
$9.06M Buy
+490,566
New +$9.06M 0.86% 45